AU2003301758A8 - Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders - Google Patents
Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disordersInfo
- Publication number
- AU2003301758A8 AU2003301758A8 AU2003301758A AU2003301758A AU2003301758A8 AU 2003301758 A8 AU2003301758 A8 AU 2003301758A8 AU 2003301758 A AU2003301758 A AU 2003301758A AU 2003301758 A AU2003301758 A AU 2003301758A AU 2003301758 A8 AU2003301758 A8 AU 2003301758A8
- Authority
- AU
- Australia
- Prior art keywords
- manifacture
- hyper
- medicament
- treatment
- proliferative disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37833002P | 2002-05-06 | 2002-05-06 | |
US60/378,330 | 2002-05-06 | ||
PCT/US2003/013784 WO2004039359A2 (en) | 2002-05-06 | 2003-05-02 | Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003301758A1 AU2003301758A1 (en) | 2004-05-25 |
AU2003301758A8 true AU2003301758A8 (en) | 2004-05-25 |
Family
ID=32230080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003301758A Abandoned AU2003301758A1 (en) | 2002-05-06 | 2003-05-02 | Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003301758A1 (en) |
WO (1) | WO2004039359A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
IL166241A (en) | 2002-07-29 | 2011-12-29 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds for use in the treatment of autoimmune diseases |
ES2421139T3 (en) | 2003-07-30 | 2013-08-29 | Rigel Pharmaceuticals, Inc. | 2,4-Pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
ES2380550T3 (en) | 2004-11-24 | 2012-05-16 | Rigel Pharmaceuticals, Inc. | Spiro-2,4-pyrimidinediamine compounds and their uses |
ES2337496T3 (en) | 2005-01-19 | 2010-04-26 | Rigel Pharmaceuticals, Inc. | PROFESSIONALS OF 2,4-PYRIMIDINDIAMINE COMPOUNDS AND THEIR USES. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0004890D0 (en) * | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
-
2003
- 2003-05-02 AU AU2003301758A patent/AU2003301758A1/en not_active Abandoned
- 2003-05-02 WO PCT/US2003/013784 patent/WO2004039359A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004039359A2 (en) | 2004-05-13 |
AU2003301758A1 (en) | 2004-05-25 |
WO2004039359A3 (en) | 2004-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1078858A1 (en) | Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders | |
AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
AU2003286728A8 (en) | Compounds for the treatment of metabolic disorders | |
PT1487828E (en) | Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases | |
AU2003258145A8 (en) | Substituted phenylindoles for the treatment of hiv | |
AU2003215150A8 (en) | Therapeutic compounds | |
GB0219660D0 (en) | Therapeutic use | |
IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
ZA200405853B (en) | Use of adapalene for the treatment of dermatological disorders | |
GB0223854D0 (en) | Therapeutic treatment | |
AU2003301758A8 (en) | Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders | |
AU2003205898A1 (en) | Combination therapy for respiratory disorders | |
AU2003296545A8 (en) | Use of a trpm8-activating substance for the treatment of tumours | |
AU2003209542A8 (en) | Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders | |
AU2003274885A1 (en) | Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders | |
GB0201025D0 (en) | The treatment of degenerative diseases | |
EP1485077A4 (en) | Drug combination therapy | |
HRP20041159A2 (en) | Combination for the treatment of airway disorders | |
GB0211413D0 (en) | Combination therapy for respiratory disorders | |
GB0224328D0 (en) | Combination therapy for respiratory disorders | |
IL164388A0 (en) | Use of ranolazine for the preparation of a medicament for the treatment of arrhymias | |
GB0213383D0 (en) | Therapeutic conditions | |
GB0223118D0 (en) | Therapeutic use | |
GB0224787D0 (en) | Therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |